Abstract
ObjectivesThis study aimed to characterize pregnancy outcomes and the incidence of induced abortion among pregnant people with a diagnosis of malignancy. Study designWe conducted a retrospective cohort study among privately insured people aged 12 to 55 years from the fourth quarter of 2015−2020 using US claims data from Merative MarketScan Research Databases. We included pregnancies from seven states with favorable policies for private insurance coverage of abortion. ResultsThere were 1471 of 183,685 (0.8%) pregnancies with a cancer diagnosis. Among those receiving anticancer therapy, 21.6% (95% CI: 14.4–30.4%) underwent induced abortion compared with 10.9% (95% CI: 10.8–11.1%) of pregnant patients without a cancer diagnosis. ConclusionsAbortion restrictions may affect many pregnant women requiring cancer treatment in early pregnancy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
